Live Breaking News & Updates on Program for appropriate technology in health

Stay informed with the latest breaking news from Program for appropriate technology in health on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Program for appropriate technology in health and stay connected to the pulse of your community

Portable AI Ultrasound Reducing Maternal Mortality in Sierra Leone

Portable AI Ultrasound Reducing Maternal Mortality in Sierra Leone
scienceafrica.co.ke - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceafrica.co.ke Daily Mail and Mail on Sunday newspapers.

Yele , Southern , Sierra-leone , Cape-verde , Liberia , Guinea , Mariatu-turray , Tenneh-jolloh , Karlin-bacher , Fatou-musa , Khadija-tolo , Katyayini-singh

PMC-MALVAC Research Project briefs stakeholders in Atebubu

PMC-MALVAC Research Project briefs stakeholders in Atebubu
modernghana.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernghana.com Daily Mail and Mail on Sunday newspapers.

Mali , Burkina-faso , Kintampo , Ghana-general- , Ghana , United-states , Ghanaian , Joseph-tang , Kwaku-poku-asante , Samuel-harrison , Edward-owusu , Kintampo-institutional-ethics-committee

World Heart Day: AstraZeneca intensifies commitment to tackle CVD across Africa World

Multinational pharmaceutical and biotechnology company, AstraZeneca, has reassured its commitment to tackling cardiovascular diseases (CVDs), across the African continent through the Healthy Heart Africa (HHA) programme.

Kenya , Ghana , Deepak-arora , Yvette-kisaka , Robert-yeboah , Program-for-appropriate-technology-in-health , World-health-day , Astrazeneca , World-health-organisation , Ghana-health-service , Healthy-heart-africa , Country-president

The US quietly terminates a controversial $125m wildlife virus hunting programme amid safety fears

Two years after launching what officials hailed as a five year flagship project for hunting viruses among wildlife to prevent human pandemics, the US Agency for International Development is shuttering the enterprise. David Willman reports

A flagship project for the controversial practice of hunting viruses among wildlife in South East Asia, Africa, and Latin America to prevent human outbreaks and pandemics is being quietly dropped by the United States Agency for International Development (USAID) after private and bipartisan criticism over the safety of such research, The BMJ has found.

For more than a decade the US government has been funding international projects engaged in identifying exotic wildlife viruses that might someday infect humans. Although critics have raised concerns over the potentially catastrophic risks of such virus hunting activities,1 hundreds of millions of dollars in unabated funding have symbolised a commitment to the effort.

The shuttering of the project, as described in a new congressional budget document and during interviews with scientists and federal policy makers, marks an abrupt retreat by the US government from wildlife virus hunting, an activity that has also been funded by the Department of Defense and the National Institutes of Health. The turnabout follows early warnings raised by sceptics—including officials in the Biden White House—that the $125m (£99m; €115m) “DEEP VZN” programme could inadvertently ignite a pandemic. The misgivings continue to resonate, as the cause of the SARS-CoV-2 pandemic, the world’s deadliest such event in a century, remains unproved.

When USAID, an arm of the US State Department, launched DEEP VZN (pronounced “deep vision”) in October 2021, the agency promoted it as “a critical next step . . . to understand and address the risks posed by zoonotic diseases that can be transmitted from animals to humans.”2 Short for “Discovery & Exploration of Emerging …

Wuhan , Hubei , China , Thailand , Washington , United-states , New-york , Bangkok , Krung-thep-mahanakhon , Washington-state-university , Idaho , White-house

Meningococcal NmCV-5 Vaccine is effective in 2-to-29-year-olds in Mali and Gambia

Bookmark 1. In this randomized controlled trial, the NmCV-5 vaccine elicited an immune response that was noninferior to the MenACWY-D vaccine in two-to-29-year-olds in Mali and Gambia. 2. The NmCV-5 vaccine had a similar incidence of adverse events as compared to the MenACWY-D vaccine. Evidence Rating Level: 1 (Excellent) Study Rundown: The highest incidence of

India , Gambia , Mali , Ethiopia , Senegal , Program-for-appropriate-technology-in-health , Minute-medicine-inc , Serum-institute-of-india , World-health-organization , Rating-level , Serum-institute

Meningococcal NmCV-5 Vaccine is effective in 2-to-29-year-olds in Mali and Gambia

1. In this randomized controlled trial, the NmCV-5 vaccine elicited an immune response that was noninferior to the MenACWY-D vaccine in two-to-29-year-olds in Mali and Gambia. 2. The NmCV-5 vaccine had a similar incidence of adverse events as compared to the MenACWY-D vaccine. Evidence Rating Level: 1 (Excellent) Study Rundown: The highest incidence of meningitis

India , Gambia , Mali , Ethiopia , Senegal , Minute-medicine-inc , World-health-organization , Serum-institute-of-india , Program-for-appropriate-technology-in-health , Rating-level , Serum-institute

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia

Researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine.

Ethiopia , Gambia , Senegal , Mali , India , Serum-institute-of-india , World-health-organization , World-health-assembly , Program-for-appropriate-technology-in-health , New-england-journal , Image-credit

World-renowned doctors receiving honorary degrees from Pitt

The School of Medicine will award Dr. Victor Dzau a doctorate in health innovation for his work in leading the global response to COVID-19. The School of Public Health will also award Dr. Chris Elias an honorary doctorate in global health on April 29.

Hong-kong , China , United-states , Thailand , Afghanistan , Cambodia , Pakistan , American , Spencer-levering , Chris-elias , Victor-dzau , Anantha-shekhar

Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control

/PRNewswire/ -- Noul Co. Ltd (CEO : David Lim) announced that it has signed an agreement with The RIGHT Foundation to conduct a global clinical studies to...

Malawi , Ghana , South-korea , Switzerland , Swiss , Korea , David-lim , Program-for-appropriate-technology-in-health , Melinda-gates-foundation , Prnewswire-noul-co , Public-health-institute , Malawi-national-malaria-control-program

Terms and Conditions

Terms & Conditions Unless otherwise noted, Program for Appropriate Technology in Health (PATH) holds the copyright for and reserves all rights to all text and images used in this website. The PATH-authored content contained in this website may be freely used and copied for educational and other noncommercial purposes, provided that any reproduction is accompanied by the following acknowledgment line: Reproduced from the PATH website at www.path.org, [current date].

United-states , Program-for-appropriate-technology-in-health , Appropriate-technology ,